Register entry

Acertis Pharmaceuticals, LLC

Data as of · How to read this entry

Registered sites
0
Active NDC listings
4
Labeller names
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 human prescription drug. By marketing category: NDA 3, ANDA 1.

Dosage formNDCs
capsule2
capsule, extended release1
tablet1
RouteNDCs
oral4
Labeller name on the listingNDCs
acertis pharmaceuticals, llc3
acertis pharmaceuticals, llc1
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
Levorphanol TartrateLevorphanol Tartratetablet, oral72989-417ANDA
PHENDIMETRAZINE TARTRATEPHENDIMETRAZINE TARTRATEcapsule, extended release, oral72989-409NDA
PrometriumProgesteronecapsule, oral72989-372NDA
PrometriumProgesteronecapsule, oral72989-373NDA
Compare

Other companies listing progesterone

Enquiry

Common questions

Is Acertis Pharmaceuticals, LLC FDA approved?
Acertis Pharmaceuticals, LLC holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Acertis Pharmaceuticals, LLC make?
4 products are listed under Acertis Pharmaceuticals, LLC in the openFDA NDC Directory, most often as capsule; capsule, extended release; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.